# The World Health Organisation says two new vaccines against the Bundibugyo virus of Ebola in the Democratic Republic of the Congo are now in safety trials in the UK and Canada. The official death toll from the DRC’s deadliest-ever Ebola outbreak stands at over three-thousand people. The province of Ituri remains the epicentre, accounting for 88-percent of deaths. Another vaccine is being developed by the US-based Moderna group. WHO says efficacy trials for all three potential vaccines should start in October or November in the DRC.
Trials for three potential vaccines against the DRC’s Ebola strain Bundibugyo will begin by November